Literature DB >> 6704013

Indications for surgical management of hyphema in patients with sickle cell trait.

T A Deutsch, R N Weinreb, M F Goldberg.   

Abstract

We analyzed 22 sickle cell trait hyphemas. Fourteen of the 22 eyes were adequately controlled with medical therapy alone, ie, the intraocular pressure averaged less than 25 mm Hg during consecutive 24-hour periods and there were no repeated transient rises of IOP above 30 mm Hg. Surgery was performed in eight eyes, because of inadequate medical control. Thirteen of the 14 medically treated eyes had acceptable levels of IOP within the first 24 hours; only one of the eight surgically treated eyes had adequate control during the first 24 hours. This suggests that control during the first 24 hours portends a good prognosis, while lack of control during that period predicts continued difficulty managing the IOP. This seems to be important in view of previous experience that suggests that these eyes do not tolerate minimal to moderate elevations in IOP as well as those of patients without sickle cell anemia.

Entities:  

Mesh:

Year:  1984        PMID: 6704013     DOI: 10.1001/archopht.1984.01040030444022

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  [Blunt ocular trauma. Part I: blunt anterior segment trauma].

Authors:  A Viestenz; M Küchle
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

2.  Clinical Characteristics and Outcomes of Hyphema in Patients with Sickle Cell Trait: 10-Year Experience at the Wilmer Eye Institute.

Authors:  Tahreem Mir; Mustafa Iftikhar; Natalie Seidel; Michelle Trang; Morton F Goldberg; Fasika A Woreta
Journal:  Clin Ophthalmol       Date:  2020-12-01

Review 3.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

4.  Global Current Practice Patterns for the Management of Hyphema.

Authors:  Sarah C Miller; Prajna Meeralakshmi; Michael J Fliotsos; Grant A Justin; Yoshihiro Yonekawa; Ariel Chen; Annette K Hoskin; Richard J Blanch; Kara M Cavuoto; Rebecca Low; Ximin Li; Matthew Gardiner; T Y Alvin Liu; Ankoor S Shah; James D Auran; Rupesh Agrawal; Fasika A Woreta
Journal:  Clin Ophthalmol       Date:  2022-09-26

5.  The injection of air/oxygen bubble into the anterior chamber of rabbits as a treatment for hyphema in patients with sickle cell disease.

Authors:  Emre Ayintap; Uğurcan Keskin; Fariz Sadigov; Mesut Coskun; Nilufer Ilhan; Sedat Motor; Hilal Semiz; Nihan Parlakfikirer
Journal:  J Ophthalmol       Date:  2014-04-07       Impact factor: 1.909

6.  Eight-ball hyphema after laser iridotomy in a patient with undiagnosed hypocellular myelodysplastic syndrome.

Authors:  Sira Arunmongkol; Yanin Suwan; Wasu Supakontanasan; Suthaphat Nilphatanakorn; Chaiwat Teekhasaenee
Journal:  Int Med Case Rep J       Date:  2018-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.